Home/Solenic Medical/James Y. Lancaster
JY

James Y. Lancaster

Chief Operating Officer and Co-Founder

Solenic Medical

Solenic Medical Pipeline

DrugIndicationPhase
SOLA2 AMF Knee SystemPeriprosthetic Joint Infection (PJI) of the kneeFirst-in-Human (under IDE)